373 related articles for article (PubMed ID: 11426861)
1. Occurrence of metronidazole and imipenem resistance among Bacteroides fragilis group clinical isolates in Hungary.
Nagy E; Sóki J; Urban E; Szoke I; Fodor E; Edwards R
Acta Biol Hung; 2001; 52(2-3):271-80. PubMed ID: 11426861
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of imipenem-resistant, cfiA-positive Bacteroides fragilis isolates from the USA, Hungary and Kuwait.
Sóki J; Fodor E; Hecht DW; Edwards R; Rotimi VO; Kerekes I; Urbán E; Nagy E
J Med Microbiol; 2004 May; 53(Pt 5):413-419. PubMed ID: 15096551
[TBL] [Abstract][Full Text] [Related]
3. Examination of cfiA-mediated carbapenem resistance in Bacteroides fragilis strains from a European antibiotic susceptibility survey.
Sóki J; Edwards R; Hedberg M; Fang H; Nagy E; Nord CE;
Int J Antimicrob Agents; 2006 Dec; 28(6):497-502. PubMed ID: 17097857
[TBL] [Abstract][Full Text] [Related]
4. Emergence of carbapenem resistance in Bacteroides fragilis in China.
Gao Q; Wu S; Xu T; Zhao X; Huang H; Hu F
Int J Antimicrob Agents; 2019 Jun; 53(6):859-863. PubMed ID: 30831235
[TBL] [Abstract][Full Text] [Related]
5. A clinical isolate of Bacteroides fragilis from Hungary with high-level resistance to imipenem.
Sóki J; Edwards R; Urbán E; Fodor E; Nagy E
J Med Microbiol; 2001 Jan; 50(1):107. PubMed ID: 11192497
[No Abstract] [Full Text] [Related]
6. Susceptibility trends of Bacteroides fragilis group and characterisation of carbapenemase-producing strains by automated REP-PCR and MALDI TOF.
Treviño M; Areses P; Peñalver MD; Cortizo S; Pardo F; del Molino ML; García-Riestra C; Hernández M; Llovo J; Regueiro BJ
Anaerobe; 2012 Feb; 18(1):37-43. PubMed ID: 22261518
[TBL] [Abstract][Full Text] [Related]
7. Update on resistance of Bacteroides fragilis group and related species with special attention to carbapenems 2006-2009.
Snydman DR; Jacobus NV; McDermott LA; Golan Y; Goldstein EJ; Harrell L; Jenkins S; Newton D; Pierson C; Rosenblatt J; Venezia R; Gorbach SL; Queenan AM; Hecht DW
Anaerobe; 2011 Aug; 17(4):147-51. PubMed ID: 21664469
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility and prevalence of resistance genes in Bacteroides fragilis isolated from blood culture bottles in two tertiary care hospitals in Japan.
Ogane K; Tarumoto N; Kodana M; Onodera A; Imai K; Sakai J; Kawamura T; Takeuchi S; Murakami T; Mitsutake K; Ikebuchi K; Maesaki S; Maeda T
Anaerobe; 2020 Aug; 64():102215. PubMed ID: 32574601
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility profiles and resistance genes for carbapenems (cfiA) and metronidazole (nim) among Bacteroides species in a Turkish University Hospital.
Toprak NU; Uzunkaya OD; Sóki J; Soyletir G
Anaerobe; 2012 Feb; 18(1):169-71. PubMed ID: 22063500
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility trends of Bacteroides fragilis group isolates from Buenos Aires, Argentina.
Fernández Canigia L; Castello L; Di Martino A; Greco G; Legaria MC; Litterio M; Predari SC; Rollet R; Rossetti A; Carloni G; Sarchi MI; Bianchini H
Rev Argent Microbiol; 2007; 39(3):156-60. PubMed ID: 17987852
[TBL] [Abstract][Full Text] [Related]
11. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
12. Antibiotic resistance pattern of Bacteroides fragilis isolated from clinical and colorectal specimens.
Jasemi S; Emaneini M; Ahmadinejad Z; Fazeli MS; Sechi LA; Sadeghpour Heravi F; Feizabadi MM
Ann Clin Microbiol Antimicrob; 2021 Apr; 20(1):27. PubMed ID: 33892721
[TBL] [Abstract][Full Text] [Related]
13. [Can meropenem E-test be used to estimate the presence of carbapenem resistance gene cfiA among Bacteroides fragilis strains?].
Toprak Ülger N; Ilki A; Ozel N; Balkan N; Söyletir G
Mikrobiyol Bul; 2011 Jul; 45(3):385-91. PubMed ID: 21935771
[TBL] [Abstract][Full Text] [Related]
14. Resistance trends of Bacteroides fragilis group over an 8-year period, 1997-2004, in Korea.
Roh KH; Kim S; Kim CK; Yum JH; Kim MS; Yong D; Lee K; Kim JM; Chong Y
Korean J Lab Med; 2009 Aug; 29(4):293-8. PubMed ID: 19726890
[TBL] [Abstract][Full Text] [Related]
15. Detection of B. fragilis group and diversity of bft enterotoxin and antibiotic resistance markers cepA, cfiA and nim among intestinal Bacteroides fragilis strains in patients with inflammatory bowel disease.
Rashidan M; Azimirad M; Alebouyeh M; Ghobakhlou M; Asadzadeh Aghdaei H; Zali MR
Anaerobe; 2018 Apr; 50():93-100. PubMed ID: 29454108
[TBL] [Abstract][Full Text] [Related]
16. The presence of antibiotic resistance genes and bft genes as well as antibiotic susceptibility testing of Bacteroides fragilis strains isolated from inpatients of the Infant Jesus Teaching Hospital, Warsaw during 2007-2012.
Kierzkowska M; Majewska A; Szymanek-Majchrzak K; Sawicka-Grzelak A; Mlynarczyk A; Mlynarczyk G
Anaerobe; 2019 Apr; 56():109-115. PubMed ID: 30844502
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of antibiotic resistance genes in Bacteroides fragilis group strains isolated in different European countries.
Eitel Z; Sóki J; Urbán E; Nagy E;
Anaerobe; 2013 Jun; 21():43-9. PubMed ID: 23500457
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the carbapenemase gene (cfiA) among clinical and normal flora isolates of Bacteroides species in Hungary.
Sóki J; Urban E; Szöke I; Fodor E; Nagy E
J Med Microbiol; 2000 May; 49(5):427-430. PubMed ID: 10798555
[TBL] [Abstract][Full Text] [Related]
19. Resistance profile of Bacteroides fragilis isolated in Brazil. Do they shelter the cfiA gene?
das Graças Silva E Souza W; Avelar KE; Antunes LC; Lobo LA; Domingues RM; de Souza Ferreira MC
J Antimicrob Chemother; 2000 Apr; 45(4):475-81. PubMed ID: 10747824
[TBL] [Abstract][Full Text] [Related]
20. First national survey of antibiotic susceptibility of the Bacteroides fragilis group: emerging resistance to carbapenems in Argentina.
Fernández-Canigia L; Litterio M; Legaria MC; Castello L; Predari SC; Di Martino A; Rossetti A; Rollet R; Carloni G; Bianchini H; Cejas D; Radice M; Gutkind G;
Antimicrob Agents Chemother; 2012 Mar; 56(3):1309-14. PubMed ID: 22232282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
